News Release

Drug Development in China - CHI Pharmaceutical Strategy Series

  • Title :Drug Development in China - CHI Pharmaceutical Strategy Series
  • Date :Oct 31, 2006
  • Location :San Francisco, CA, USA
  • Description :Dr. Ying Luo, CEO of Shanghai Genomics and COO of GNI, presents at the "Drug Development in China - Strategies for Launching Discovery and Development Activities" in San Francisco, California. The meeting is part of the CHI Pharmaceutical Strategy Series. His talk focuses on the need to build a balance product pipeline in China.